BioProcess Insiderâ€™s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends.
With a panel of industry experts, editor Dan Stanton discusses recent mergers and acquisitions in the bioprocess space, bottlenecks within the manufacturing sector, the continued head- and tailwinds COVID-19 is placing on businesses, and the evolution of the cell and gene therapy landscape and what that means for supply chains.
Frank Orlowski, Director of Business Development, Latham Biopharm Group
Steven Lee, CEO, Eden Biologics
Joe Scott, Vice President, Supply Chain Operations, Avid Bioservices